2000
DOI: 10.1038/sj.bmt.1702663
|View full text |Cite
|
Sign up to set email alerts
|

Significant MLR but not CTL responses against recipient antigens generated in T cells from bone marrow chimeras recovered from acute GVHD

Abstract: BMT is an effective therapy for many otherwise lethal diseases including leukemia. 1 GVHD is one of the most critical complications accompanying BMT. [2][3][4] To reduce the incidence of GVHD, a number of methods have been established in murine and human systems. 4-11 Elimination of mature T cells from donor BM cells (BMC) is one of the most reliable methods. However, the complete elimination of allogeneic T cells has been shown to increase the frequency of failure of allogeneic engraftment. [12][13][14][15][1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2002
2002
2008
2008

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 43 publications
1
1
0
Order By: Relevance
“…In our present model of IUT, enhanced MLR but decreased CTL responses were observed with increased CD4/ CD8 ratios and IL-2 production. The finding that anti-donor MLR, but not CTL responses, increased following transplantation was previously reported [33][34][35] and was related to the expansion of CD4 cells. Similarly, we have observed significant expansion of CD4 cells but not CD8 cells upon reexposure to the donor cells during the postnatal boosts (Fig.…”
Section: Discussionsupporting
confidence: 67%
“…In our present model of IUT, enhanced MLR but decreased CTL responses were observed with increased CD4/ CD8 ratios and IL-2 production. The finding that anti-donor MLR, but not CTL responses, increased following transplantation was previously reported [33][34][35] and was related to the expansion of CD4 cells. Similarly, we have observed significant expansion of CD4 cells but not CD8 cells upon reexposure to the donor cells during the postnatal boosts (Fig.…”
Section: Discussionsupporting
confidence: 67%
“…T cells purified from human PBMCs using nylon wool columns, were used as responders (23), and DCs, which had been treated with vehicle, LPS, WKYMVm plus LPS, or wkymvm plus LPS were used as stimulator cells. A total of 1 ϫ 10 5 allogeneic T cells were added to DCs (1 ϫ 10 4 , 3 ϫ 10 3 , 1 ϫ 10 3 , or 3 ϫ 10 2 ) in 96-well tissue culture plates containing 0.2 ml of medium per well.…”
Section: Measurement Of Allostimulatory Activitymentioning
confidence: 99%